Time to Viral Suppression Is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated With Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin

Journal of Viral Hepatitis - United Kingdom
doi 10.1111/jvh.12641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for Chronic HCV Infection in US Veterans With Psychiatric Disorders

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Real-World Experience With Ombitasvir/Paritaprevir Boosted With Ritonavir and Possibly Combined With Dasabuvir and Ribavirin in HCV Infection

Clinical and Experimental Hepatology
Hepatology
2016English

Drug-Drug Interactions Between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir With or Without Dasabuvir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Trend of Estimated Glomerular Filtration Rate During Ombistasvir/Paritaprevir/Ritonavir Plus Dasabuvir ± Ribavirin in HIV/HCV Co-Infected Patients

PLoS ONE
Multidisciplinary
2018English

Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)

Health Science Reports
2019English

A Real-Life Data on the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +Ribavirin in Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Serbia

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Effect of Co-Medications on Paritaprevir, Ritonavir, Ombitasvir, Dasabuvir and Ribavirin Pharmacokinetics: Analysis of Data From Seven Phase II/III Trials

Antiviral Therapy
Infectious DiseasesPharmacology
2016English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology
VirologyInfectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy